Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Vitamin D in GVHD prophylaxis in patients undergoing allogeneic stem cell transplantation
2020-003994-23Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cholecalciferol in graft-versus-host disease (GVHD) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Effectiveness of vitamin D in GVHD in terms of presentation and severity. Started Jun 2021; status: active.
02
Drugs
cholecalciferol
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on 2020-003994-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003994-23.